CJ Gelatine Products Ltd. Share Price

Pursuant to Regulation 29 and other relevant regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, C.J.Gelatine Products has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, the 14th Day of August, 2026 at 1:30 PM (IST) at Factory premises of the Company situated at 21, New Industrial Area, Mandideep, Raisen, 462 046 (M.P.), to consider, to approve and to transact the following business(s): 1. To consider and approve the unaudited financial results of the Company for the quarter ended June 30, 2026 along with the Limited Review Report; 2. To approve and adopt Boards’ Report of the Company and its annexures thereto for the financial year ended March 31, 2026; 3. To fix and decide the date of Closure of Register of Member and Share Transfer book for the purpose of 46th Annual General Meeting; 4. To fix and decide the ‘Cut-off’ date for the Purpose of determining the eligibility of Shareholders for remote e-voting and voting during the 46th Annual General Meeting; 5. To fix and decide the remote e-voting and voting period for the 46th Annual General Meeting; 6. To appoint a Scrutinizer for the purpose of remote e-voting/voting for 46th Annual General Meeting; 7. To fix the day, date and time of 46th Annual General Meeting of the Company and approve the Notice for calling the said meeting; and 8. Any other matter with the permission of Chairman.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Punjab Chemicals And Crop Protection has informed that a Post Results Conference Call to discuss the Company's results and performance for the Q2 FY27 has been scheduled on Wednesday, November 4, 2026 at 2:30 pm (lST). The intimation with required information is attached.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Titan Biotech has informed that the Board of Directors at its meeting held on September 03, 2026 had recommended Issuance of Bonus Equity Shares, subject to shareholders’ approval. The Shareholders of the Company subsequently approved the issuance of Bonus Equity Shares at 34th Annual General Meeting held on September 29, 2026. The Board of Directors the Company at its meeting held on October 26, 2026, has approved the allotment of 1,03,29,625 fully paid-up bonus equity shares of Rs. 2/- each in the ratio of 1:4 i.e. 1 new fully paid-up equity share of Rs. 2/- for every 4 existing fully paid-up equity share of Rs. 2/- to the eligible shareholders of the Company whose name appeared in the Register of Members/ Register of Beneficial Owners as on October 23, 2026, being the record date fixed for this purpose. The said Bonus Equity Shares would be credited to the Shareholders within the statutory time limits. Consequent to the aforesaid allotment, the paid-up Equity Share Capital of the Company shall stand increased from Rs. 8,26,37,000/- to Rs. 10,32,96,250 /-. The Board Meeting commenced at 09:30 AM and concluded at 09:55 AM. 

The above information is a part of company’s filings submitted to BSE.